Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abnormalities, Multiple | 3 | 2019 | 176 | 0.840 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 22 | 0.610 |
Why?
|
| Hematologic Diseases | 1 | 2018 | 55 | 0.600 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2017 | 1 | 0.590 |
Why?
|
| COUP Transcription Factor I | 1 | 2017 | 2 | 0.590 |
Why?
|
| Brain Diseases | 2 | 2017 | 124 | 0.590 |
Why?
|
| Face | 1 | 2018 | 163 | 0.550 |
Why?
|
| Hodgkin Disease | 1 | 2018 | 121 | 0.550 |
Why?
|
| Intellectual Disability | 4 | 2024 | 127 | 0.510 |
Why?
|
| Corpus Striatum | 1 | 2015 | 126 | 0.460 |
Why?
|
| Metformin | 1 | 2015 | 274 | 0.390 |
Why?
|
| Exome | 4 | 2020 | 200 | 0.370 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 339 | 0.330 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 1011 | 0.290 |
Why?
|
| Phenotype | 8 | 2024 | 2784 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3039 | 0.230 |
Why?
|
| Developmental Disabilities | 4 | 2024 | 236 | 0.230 |
Why?
|
| Leukoencephalopathies | 1 | 2024 | 21 | 0.220 |
Why?
|
| Language Development Disorders | 2 | 2017 | 38 | 0.180 |
Why?
|
| Syntaxin 1 | 1 | 2019 | 14 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2019 | 88 | 0.160 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2019 | 16 | 0.160 |
Why?
|
| F-Box Proteins | 1 | 2019 | 20 | 0.160 |
Why?
|
| YY1 Transcription Factor | 1 | 2018 | 27 | 0.160 |
Why?
|
| Myasthenia Gravis | 1 | 2018 | 18 | 0.160 |
Why?
|
| Mutation | 5 | 2024 | 3338 | 0.150 |
Why?
|
| Behavior | 1 | 2019 | 91 | 0.150 |
Why?
|
| Epileptic Syndromes | 1 | 2019 | 66 | 0.150 |
Why?
|
| Optic Atrophy | 1 | 2017 | 10 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2024 | 1311 | 0.150 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2017 | 4 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2017 | 31 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 31 | 0.130 |
Why?
|
| Polycythemia | 1 | 2016 | 23 | 0.130 |
Why?
|
| Syndrome | 3 | 2024 | 330 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 110 | 0.120 |
Why?
|
| Seizures | 1 | 2017 | 337 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2024 | 1526 | 0.110 |
Why?
|
| DNA | 2 | 2017 | 1350 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2019 | 868 | 0.110 |
Why?
|
| Epilepsy | 1 | 2017 | 278 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2016 | 361 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 322 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2017 | 1368 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2019 | 9115 | 0.100 |
Why?
|
| Facies | 2 | 2024 | 20 | 0.100 |
Why?
|
| Humans | 11 | 2024 | 114049 | 0.080 |
Why?
|
| Heterozygote | 2 | 2019 | 250 | 0.080 |
Why?
|
| Genetic Testing | 2 | 2020 | 381 | 0.070 |
Why?
|
| Female | 6 | 2019 | 59326 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2019 | 294 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 17802 | 0.060 |
Why?
|
| Child | 3 | 2024 | 18404 | 0.060 |
Why?
|
| Male | 4 | 2019 | 55398 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2024 | 56 | 0.050 |
Why?
|
| Adult | 3 | 2018 | 30377 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2019 | 28 | 0.040 |
Why?
|
| Seizures, Febrile | 1 | 2019 | 19 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 36 | 0.040 |
Why?
|
| Genotype | 1 | 2024 | 1757 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 460 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 29 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 134 | 0.040 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2019 | 45 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 150 | 0.040 |
Why?
|
| Xenopus | 1 | 2017 | 94 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 356 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2019 | 178 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2019 | 359 | 0.030 |
Why?
|
| Oocytes | 1 | 2017 | 169 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 722 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 437 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 149 | 0.030 |
Why?
|
| Infant | 2 | 2019 | 7944 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2016 | 374 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2272 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3397 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 5038 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 10446 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 31565 | 0.010 |
Why?
|